Shapiro David bought DSGN
March 31, 2026 · Form 4 insider transaction
Shapiro David bought 7,500 shares of Design Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$0.00
Total value
N/A
InsiderShapiro David
RoleDirector
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after7,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option will vest in equal monthly installments over 12 months following March 31, 2026.